| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $731.4M | +61.9% |
| Cost of Revenue | $239.2M | +94.5% |
| Gross Profit | $492.1M | +49.7% |
| R&D Expense | $196.2M | +30.3% |
| SG&A Expense | $154.4M | +56.3% |
| Operating Income | -$7.7M | -162.8% |
| Pre-tax Income | -$49.7M | -65.2% |
| Income Tax | -$9.4M | +97.9% |
| Net Income | -$38.8M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $91.2M | -48.6% |
| Short-term Investments | $0 | -100.0% |
| Accounts Receivable | $167.3M | +57.7% |
| Current Assets | $295.6M | -23.2% |
| Total Assets | $3.03B | +159.2% |
| Current Liabilities | $161.3M | +109.4% |
| Long-term Debt | $822.6M | +1799.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $175.9M | +136.7% |
| Capital Expenditures | $11.6M | +119.7% |
| Investing Cash Flow | -$988.1M | -1675.7% |
| Financing Cash Flow | $725.4M | +1276.3% |
| Free Cash Flow | $164.3M | +138.0% |
| -109.1% |
| EPS (Basic) | -$0.14 | -107.3% |
| EPS (Diluted) | -$0.14 | -108.3% |
| Total Liabilities |
| $1.00B |
| +618.3% |
| Stockholders' Equity | $2.02B | +100.5% |